Patent · US Active

Use of succinate dehydrogenase inhibitors and/or respiratory chain complex III inhibitors for improving the ratio of harmful to beneficial microorganisms

US9788540B2 · kind B2 · utility

1Cited by

5References

17Claims

0Family size

Assignee

Bayer Intellectual Property GmbH · DE

Inventors

Lorianne Fought · Kerman, US
Herbert Young · Shalimar, US
George Hauley Musson, IV · Raleigh, US
Gilbert Labourdette · Montceau-les-Mines, FR
Dominique Steiger · Goldkronach, DE
Heiko Rieck · Burscheid, DE

Key dates

Filing date	Jul 25, 2011
Grant date	Oct 17, 2017
Priority date	—
Expiry date	Jul 25, 2031

Classification

Technology area (CPC A)Human Necessities
CPC primaryA01N43/40
WIPO fieldBasic materials chemistry
WIPO sectorChemistry

Abstract

The present invention relates to the use of succinate dehydrogenase inhibitors and/or complex III inhibitors for controlling undesired fungal pathogens and simultaneously improving the ratio of harmful to beneficial microorganisms in crops and to a method for treating crops or parts of crops for controlling undesired fungal pathogens and simultaneously improving the ratio of harmful to beneficial microorganisms by treating the crops or parts of crops with a succinate dehydrogenase inhibitor and/or a complex III inhibitor.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.